From the publishers of JADPRO
Multiple Myeloma
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
The New Role of MRD Testing in Trials and Treatments
Last Updated: Wednesday, July 24, 2024
Advertisement
News & Literature Highlights
NPJ Digital Medicine
Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma
Journal of Blood Medicine
Secondary polycythemia may be an early clinical manifestation of multiple myeloma: A case report
Japanese Journal of Radiology
Review of whole-body magnetic resonance imaging in multiple myeloma
Frontiers in Oncology
Advancements in microenvironment-based therapies: Transforming the landscape of multiple myeloma treatment
Journal of the Advanced Practitioner in Oncology
Patient-reported outcomes with belantamab mafodotin treatment in patients with triple-class refractory multiple myeloma
Cancer Discovery
CAR T-cell availability for multiple myeloma improving but still limited
Platelets
Multiple myeloma and its treatment contribute to increased platelet reactivity
European Journal of Haematology
Treatment sequences and drug costs from diagnosis to death in multiple myeloma
Transplantation and Cellular Therapy
Ethical challenges in CAR-T slot allocations
Nature
Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders
Advertisement
Case Studies
Single Solitary Plasmacytoma to Active Myeloma
A Heavily Treated Relapsed/Refractory Multiple Myeloma Patient on Talquetamab
First Relapse of Multiple Myeloma Patient
Advertisement
Quizzes
Test your knowledge of newly diagnosed multiple myeloma
Test your knowledge in a first relapse case
Test your knowledge of relapsed multiple myeloma and bispecific antibodies